Breakdown | TTM | Dec 2025 | Dec 2023 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 20.80B | 21.24B | 25.57B | 15.48B | 24.73B | 16.12B |
Gross Profit | 7.65B | 8.60B | 10.42B | 3.17B | 10.01B | 6.93B |
EBITDA | 1.66B | 1.87B | 4.10B | 119.50M | 4.81B | 3.11B |
Net Income | -106.01M | -106.01M | 2.38B | -1.06B | 3.04B | 1.86B |
Balance Sheet | ||||||
Total Assets | 30.85B | 30.85B | 31.98B | 30.40B | 27.98B | 19.74B |
Cash, Cash Equivalents and Short-Term Investments | 311.77M | 311.77M | 1.52B | 330.74M | 117.22M | 1.23B |
Total Debt | 8.29B | 8.29B | 8.24B | 8.37B | 4.99B | 2.68B |
Total Liabilities | 15.70B | 15.70B | 15.29B | 15.12B | 13.31B | 8.01B |
Stockholders Equity | 15.15B | 15.15B | 16.69B | 15.28B | 14.66B | 11.73B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -226.88M | -2.61B | -165.29M | -1.79B | 1.24B |
Operating Cash Flow | 0.00 | 662.22M | 2.04B | 2.50B | 648.32M | 3.33B |
Investing Cash Flow | 0.00 | 309.70M | -4.18B | -1.78B | -1.33B | -3.07B |
Financing Cash Flow | 0.00 | -913.88M | 2.34B | -854.77M | 577.19M | -142.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ₹26.12B | 23.92 | 0.35% | -8.66% | -17.63% | ||
69 Neutral | ₹26.49B | 25.22 | 0.89% | 2.73% | -11.40% | ||
63 Neutral | ₹24.73B | 345.69 | 0.19% | 2.47% | -72.80% | ||
60 Neutral | ₹22.25B | 63.43 | 0.64% | 6.88% | 94.21% | ||
52 Neutral | ₹10.52B | 310.83 | 2.51% | -0.66% | -125.21% | ||
44 Neutral | AU$1.54B | -7.28 | -27.94% | 4.40% | -3.13% | -36.41% | |
43 Neutral | ₹21.72B | ― | ― | ― | ― |
Meghmani Organics Limited held its 6th Annual General Meeting on June 28, 2025, where all resolutions were approved with the requisite majority. The meeting, conducted via video conferencing, included the adoption of audited financial statements and the reappointment of directors, reflecting the company’s commitment to transparency and governance.